Referências

1. Lee P.A., Consensus statement on management of intersex disorders. International Consensus Conference on Intersex, Pediatrics., 118, 2, pp. e488-e500, (2006)
2. Mendonca B.B., Inacio M., Arnhold I.J., Et al., Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase 3 deficiency, Diagnosis, psychological evaluation, Manag Med (Baltim), 79, 5, pp. 299-309, (2000)
3. Andersson S., Moghrabi N., Physiology and molecular genetics of 17 beta-hydroxysteroid dehydrogenases, Steroids., 62, 1, pp. 143-147, (1997)
4. Saez J.M., De Peretti E., Morera A.M., David M., Bertrand J., Familial male pseudohermaphroditism with gynecomastia due to a testicular 17-ketosteroid reductase defect. I. Studies in vivo, J Clin Endocrinol Metab, 32, 5, pp. 604-610, (1971)
5. George M.M., New M.I., Ten S., Sultan C., Bhangoo A., The clinical and molecular heterogeneity of 17betaHSD-3 enzyme deficiency, Horm Res Paediatr, 74, 4, pp. 229-240, (2010)
6. Lee Y.S., Kirk J.M., Stanhope R.G., Et al., Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls, Clin Endocrinol, 67, 1, pp. 20-28, (2007)
7. Andersson S., Geissler W.M., Wu L., Et al., Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency, J Clin Endocrinol Metab, 81, 1, pp. 130-136, (1996)
8. Boehmer A.L.M., Brinkmann A.O., Sandkuijl L.A., Et al., 17 beta-hydroxysteroid dehydrogenase-3 deficiency: diagnosis, phenotypic variability, population genetics, and worldwide distribution of ancient and de novo mutations, J Clin Endocrinol & Metab, 84, 12, pp. 4713-4721, (1999)
9. Lee P.A., Nordenstrom A., Houk C.P., Et al., Global disorders of sex development update since 2006: perceptions, approach and care, Horm Res Paediatr, 85, 3, pp. 158-180, (2016)
10. Parisi M.A., Ramsdell L.A., Burns M.W., Et al., A gender assessment team: experience with 250 patients over a period of 25 years, Genet Med, 9, 6, pp. 348-357, (2007)
11. Mains L.M., Vakili B., Lacassie Y., Andersson S., Lindqvist A., Rock J.A., 17beta-hydroxysteroid dehydrogenase 3 deficiency in a male pseudohermaphrodite, Fertil Steril, 89, 1, (2008)
12. Chuang J., Vallerie A., Breech L., Et al., Complexities of gender assignment in 17beta-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?, Int J Pediatr Endocrinol, 2013, 1, (2013)
13. Rosler A., 17 beta-hydroxysteroid dehydrogenase 3 deficiency in the Mediterranean population, Pediatr Endocrinol Rev, 3, pp. 455-461, (2006)
14. Rosler A., Silverstein S., Abeliovich D.A., R80Q) mutation in 17 beta-hydroxysteroid dehydrogenase type 3 gene among Arabs of Israel is associated with pseudohermaphroditism in males and normal asymptomatic females, J Clin Endocrinol Metab, 81, 5, pp. 1827-1831, (1996)
15. Rosler A., Kohn G., Male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency: studies on the natural history of the defect and effect of androgens on gender role, J Steroid Biochem, 19, 1B, pp. 663-674, (1983)
16. Rohle R., Gehrmann K., Szarras-Czapnik M., Et al., Participation of adults with disorders/differences of sex development (DSD) in the clinical study dsd-LIFE: design, methodology, recruitment, data quality and study population, BMC Endocr Disord, 17, 1, (2017)
17. Labrie F., Luu-The V., Lin S.X., Et al., The key role of 17 beta-hydroxysteroid dehydrogenases in sex steroid biology, Steroids., 62, 1, pp. 148-158, (1997)
18. Labrie F., Luu-The V., Lin S.X., Simard J., Labrie C., Role of 17 beta-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues, Trends Endocrinol Metab, 11, 10, pp. 421-427, (2000)
19. Arnhold I.J., Mendonca B.B., Diaz J.A., Et al., Prepubertal male pseudohermaphroditism due to 17-ketosteroid reductase deficiency: diagnostic value of a hCG test and lack of HLA association, J Endocrinol Invest, 11, 4, pp. 319-322, (1988)
20. Bertelloni S., Maggio M.C., Federico G., Baroncelli G., Hiort O., 17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal, Gynecol Endocrinol, 22, 9, pp. 488-494, (2006)
21. Geissler W.M., Davis D.L., Wu L., Et al., Male pseudohermaphroditism caused by mutations of testicular 17 beta- hydroxysteroid dehydrogenase 3, Nat Genet, 7, 1, pp. 34-39, (1994)
22. Cohen-Kettenis P.T., Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency, Arch Sex Behav, 34, 4, pp. 399-410, (2005)
23. Yang Z., Ye L., Wang W., Et al., 17β-Hydroxysteroid dehydrogenase 3 deficiency: Three case reports and a systematic review, J Steroid Biochem Mol Biol, 174, pp. 141-145, (2017)
24. Ulloa-Aguirre A., Bassol S., Poo J., Et al., Endocrine and biochemical studies in a 46,XY phenotypically male infant with 17-ketosteroid reductase deficiency, J Clin Endocrinol Metab, 60, 4, pp. 639-643, (1985)
25. Rosler A., Belanger A., Labrie F., Mechanisms of androgen production in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency, J Clin Endocrinol Metab, 75, 3, pp. 773-778, (1992)
26. Moeller G., Adamski J., Integrated view on 17beta-hydroxysteroid dehydrogenases, Mol Cell Endocrinol, 301, 1-2, pp. 7-19, (2009)
27. Marchais-Oberwinkler S., Henn C., Moller G., Et al., 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development, J Steroid Biochem Mol Biol, 125, 1-2, pp. 66-82, (2011)
28. Werner R., Kulle A., Sommerfeld I., Et al., Testosterone synthesis in patients with 17beta-hydroxysteroid dehydrogenase 3 deficiency, Sex Dev., 6, 4, pp. 161-168, (2012)
29. Hoppe U., Holterhus P.M., Wunsch L., Et al., Tissue-specific transcription profiles of sex steroid biosynthesis enzymes and the androgen receptor, J Mol Med, 84, 8, pp. 651-659, (2006)
30. Pelletier G., Expression of steroidogenic enzymes and sex-steroid receptors in human prostate, Best Pract Res Clin Endocrinol & Metab, 22, 2, pp. 223-228, (2008)
31. Phelan N., Williams E.L., Cardamone S., Et al., Screening for mutations in 17β-hydroxysteroid dehydrogenase and androgen receptor in women presenting with partially virilised 46,XY disorders of sex development, Eur J Endocrinol, 172, 6, pp. 745-751, (2015)
32. Rogers D.G., Chasalow F.I., Blethen S.L., Partial deficiency in 17-ketosteroid reductase presenting as gynecomastia, Steroids., 45, 2, pp. 195-200, (1985)
33. Castro-Magana M., Angulo M., Uy J., Male hypogonadism with gynecomastia caused by late-onset deficiency of testicular 17-ketosteroid reductase, N Engl J Med, 328, 18, pp. 1297-1301, (1993)
34. Faisal Ahmed S., Iqbal A., Hughes I.A., The testosterone:androstenedione ratio in male undermasculinization, Clin Endocrinol, 53, 6, pp. 697-702, (2000)
35. Domenice S., Batista R.L., Arnhold I.J.P., Sircili M.H., Costa E.M.F., Mendonca B.B., 46, XY differences of sexual development., Endotext [Internet]. MDText.com, Inc., (2022)
36. Bertelloni S., Balsamo A., Giordani L., Et al., 17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence, J Endocrinol Invest, 32, 8, pp. 666-670, (2009)
37. Kulle A., Krone N., Holterhus P.M., Et al., Steroid hormone analysis in diagnosis and treatment of DSD: position paper of EU COST Action BM 1303 ‘DSDnet’, Eur J Endocrinol, 176, 5, pp. P1-P9, (2017)
38. Khattab A., Yuen T., Yau M., Et al., Pitfalls in hormonal diagnosis of 17-beta hydroxysteroid dehydrogenase III deficiency, J Pediatr Endocrinol Metab, 28, 5-6, pp. 623-628, (2015)
39. Bilbao J.R., Loridan L., Audi L., Gonzalo E., Castano L., A novel missense (R80W) mutation in 17-beta-hydroxysteroid dehydrogenase type 3 gene associated with male pseudohermaphroditism, Eur J Endocrinol, 139, 3, pp. 330-333, (1998)
40. Imperato-McGinley J., Peterson R.E., Stoller R., Goodwin W.E., Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty, J Clin Endocrinol Metab, 49, 3, pp. 391-395, (1979)
41. Inacio M., Sircili M.H., Brito V.N., Et al., 46,XY DSD due to 17beta-HSD3 deficiency and 5alpha-reductase type 2 deficiency, Adv Exp Med Biol, 707, pp. 9-14, (2011)
42. Mendonca B.B., Domenice S., Arnhold I.J., Costa E.M., 46,XY disorders of sex development, Clin Endocrinol, (2008)
43. Telles de Sousa Castro C.C., Guaragna-Filho G., Calais F.L., Et al., Clinical and molecular spectrum of patients with 17 beta-hydroxysteroid dehydrogenase type 3 (17-beta-HSD3) deficiency, Arquivos Brasileiros De Endocrinologia E Metabologia, 56, 8, pp. 533-539, (2012)
44. Massanyi E.Z., Gearhart J.P., Kolp L.A., Migeon C.J., Novel mutation among two sisters with 17beta hydroxysteroid dehydrogenase type 3 deficiency, Urology., 81, 5, pp. 1069-1071, (2013)
45. Ellaithi M., Werner R., Riepe F.G., Et al., 46,XY disorder of sex development in a Sudanese patient caused by a novel mutation in the HSD17B3 gene, Sex Dev, 8, 4, pp. 151-155, (2014)
46. Engeli R.T., Rhouma B.B., Sager C.P., Et al., Biochemical analyses and molecular modeling explain the functional loss of 17β-hydroxysteroid dehydrogenase 3 mutant G133R in three Tunisian patients with 46, XY disorders of sex development, J Steroid Biochem Mol Biol, 155, pp. 147-154, (2016)
47. Hassan H.A., Mazen I., Gad Y.Z., Ali O.S., Mekkawy M., Essawi M.L., A novel nonsense mutation in exon 1 of HSD17B3 gene in an Egyptian 46,XY adult female presenting with primary amenorrhea, Sex Dev, 7, 6, pp. 277-281, (2013)
48. Tuhan H.U., Anik A., Catli G., Et al., A novel missense mutation in HSD17B3 gene in a 46, XY adolescent presenting with primary amenorrhea and virilization at puberty, Clinica Chim Acta, 438, pp. 154-156, (2015)
49. Omrani M.D., Adamovic T., Grandell U., Saleh-Gargari S., Nordenskjold A., 17-beta-hydroxysteroid dehydrogenase type 3 deficiency in three adult Iranian siblings, Sex Dev, 5, 6, pp. 273-276, (2011)
50. Mendonca B.B., Gomes N.L., Costa E.M., Et al., 46,XY disorder of sex development (DSD) due to 17beta-hydroxysteroid dehydrogenase type 3 deficiency, J Steroid Biochem Mol Biol, (2016)
51. McKeever B.M., Hawkins B.K., Geissler W.M., Et al., Amino acid substitution of arginine 80 in 17-hydroxysteroid dehydrogenase type 3 and its effect on NADPH cofactor binding and oxidation/reduction kinetics, Biochim Biophys Acta, 1601, 1, pp. 29-37, (2002)
52. Yazawa T., Imamichi Y., Uwada J., Et al., Evaluation of 17β-hydroxysteroid dehydrogenase activity using androgen receptor-mediated transactivation, J Steroid Biochem Mol Biol, 196, (2020)
53. Baxter R.M., Arboleda V.A., Lee H., Et al., Exome sequencing for the diagnosis of 46,XY disorders of sex development, J Clin Endocrinol Metab, 100, 2, pp. E333-E344, (2015)
54. Mendonca B.B., Arnhold I.J., Bloise W., Andersson S., Russell D.W., Wilson J.D., 17Beta-hydroxysteroid dehydrogenase 3 deficiency in women, J Clin Endocrinol Metab, 84, 2, pp. 802-804, (1999)
55. Hersmus R., van Bever Y., Wolffenbuttel K.P., Biermann K., Cools M., Looijenga L.H., The biology of germ cell tumors in disorders of sex development, Clin Genet, 91, 2, pp. 292-301, (2017)
56. Cools M., Drop S.L., Wolffenbuttel K.P., Oosterhuis J.W., Looijenga L.H., Germ cell tumors in the intersex gonad: old paths, new directions, moving frontiers, Endocr Rev, 27, 5, pp. 468-484, (2006)
57. Cools M., van Aerde K., Kersemaekers A.M., Et al., Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes, J Clin Endocrinol Metab, 90, 9, pp. 5295-5303, (2005)
58. Wunsch L., Holterhus P.M., Wessel L., Hiort O., Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis, BJU Int, (2012)
59. Siminas S., Kokai G., Kenny S.E., Complete androgen insensitivity syndrome associated with bilateral sertoli cell adenomas and paratesticular leiomyomas: Case report and review of the literature, J Pediatric Urol, (2012)
60. Cools M., Nordenstrom A., Robeva R., Et al., Caring for individuals with a difference of sex development (DSD): a Consensus Statement, Nat Rev Endocrinol, 14, 7, pp. 415-429, (2018)
61. Wisniewski A.B., Batista R.L., Costa E.M.F., Et al., Management of 46,XY differences/disorders of sex development (DSD) throughout life, Endocr Rev, 40, 6, pp. 1547-1572, (2019)
62. Hughes I.A., Houk C., Ahmed S.F., Lee P.A., Consensus statement on management of intersex disorders, Arch Dis Child, 91, 7, pp. 554-563, (2006)
63. Idrees M.T., Ulbright T.M., Oliva E., Et al., The World Health Organization 2016 classification of testicular non-germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel, Histopathology, 70, 4, pp. 513-521, (2017)
64. Williamson S.R., Delahunt B., Magi-Galluzzi C., Et al., The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel, Histopathology, 70, 3, pp. 335-346, (2017)
65. de Jong J., Stoop H., Dohle G.R., Et al., Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours, J Pathol, 206, 2, pp. 242-249, (2005)
66. Cools M., Stoop H., Kersemaekers A.M., Et al., Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads, J Clin Endocrinol Metab, 91, 6, pp. 2404-2413, (2006)
67. Kersemaekers A.M., Honecker F., Stoop H., Et al., Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY, Hum Pathol, 36, 5, pp. 512-521, (2005)
68. Folsom L.J., Hjaige M., Liu J., Eugster E.A., Auchus R.J., Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency, Mol Cell Endocrinol, 489, pp. 3-8, (2019)
69. Gomes N.L., Chetty T., Jorgensen A., Mitchell R.T., Disorders of sex development-novel regulators, impacts on fertility, and options for fertility preservation, Int J Mol Sci, 21, 7, (2020)
70. Gravholt C.H., Andersen N.H., Conway G.S., Et al., Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting, Eur J Endocrinol, 177, 3, pp. G1-G70, (2017)
71. van de Grift T.C., Kreukels B.P.C., dsd-LIFE. Breast development and satisfaction in women with disorders/differences of sex development, Hum Reprod, 34, 12, pp. 2410-2417, (2019)
72. Farkas A., Rosler A., Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency, Eur J Pediatr, 152, pp. S88-S90, (1993)
73. Loch Batista R., Inacio M., Prado Arnhold I.J., Et al., Psychosexual aspects, effects of prenatal androgen exposure, and gender change in 46,XY disorders of sex development, J Clin Endocrinol Metab, 104, 4, pp. 1160-1170, (2019)